Similar articles

• Meperidine-induced QTc-interval prolongation: prevalence, risk factors, and correlation to plasma drug and metabolite concentrations
.

  Keller GA, Villa Etchegoyen MC, Fernández N, Olivera NM, Quiroga PN, Diez RA, Di Girolamo G. Keller GA, et al. Int J Clin Pharmacol Ther. 2017 Mar;55(3):275-285. doi: 10.5414/CP202612. Int J Clin Pharmacol Ther. 2017. PMID: 27509828
• Methadone-associated QT prolongation and torsades de pointes.

  George S. George S. Br J Hosp Med (Lond). 2007 Apr;68(4):221. doi: 10.12968/hmed.2007.68.4.221. Br J Hosp Med (Lond). 2007. PMID: 17465110 No abstract available.
• In reply: one prescription for the opioid crisis.

  Bicket MC, Durbhakula S. Bicket MC, et al. Reg Anesth Pain Med. 2020 Oct;45(10):844. doi: 10.1136/rapm-2020-101413. Epub 2020 Jul 13. Reg Anesth Pain Med. 2020. PMID: 32665452 No abstract available.
• Opioids-Induced Long QT Syndrome: A Challenge to Cardiac Health.

  Hu J, Song Y, Huang X, Li C, Jin X, Cen L, Zhang C, Ding B, Lian J. Hu J, et al. Cardiovasc Toxicol. 2024 May;24(5):472-480. doi: 10.1007/s12012-024-09853-6. Epub 2024 Apr 17. Cardiovasc Toxicol. 2024. PMID: 38630336 Free PMC article. Review.
• Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice.

  Isbister GK, Page CB. Isbister GK, et al. Br J Clin Pharmacol. 2013 Jul;76(1):48-57. doi: 10.1111/bcp.12040. Br J Clin Pharmacol. 2013. PMID: 23167578 Free PMC article. Review.